572 related articles for article (PubMed ID: 30637623)
1. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
3. Microsurgical therapy of pituitary adenomas.
Mortini P; Barzaghi LR; Albano L; Panni P; Losa M
Endocrine; 2018 Jan; 59(1):72-81. PubMed ID: 29067608
[TBL] [Abstract][Full Text] [Related]
4. Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.
O'Brien T; O'Riordan DS; Gharib H; Scheithauer BW; Ebersold MJ; van Heerden JA
Neurosurgery; 1996 Aug; 39(2):273-8; discussion 278-9. PubMed ID: 8832664
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
6. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
8. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
9. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
Kobayashi T
Prog Neurol Surg; 2009; 22():77-95. PubMed ID: 18948721
[TBL] [Abstract][Full Text] [Related]
11. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Carney Complex-Associated Pituitary Pathology.
Lonser RR; Mehta GU; Kindzelski BA; Ray-Chaudhury A; Vortmeyer AO; Dickerman R; Oldfield EH
Neurosurgery; 2017 May; 80(5):780-786. PubMed ID: 27509071
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
14. [Trans-septo-sphenoidal operation for pituitary adenoma in 92 patients: results and follow-up endocrine studies].
Gasser RW; Spoendlin H; Finkenstedt G; Pallua AK; Aichner F; Braunsteiner H
Wien Klin Wochenschr; 1993; 105(7):204-7. PubMed ID: 8385381
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatments for 7 pituitary adenomas in multiple endocrine neoplasia type 1].
Tanaka Y; Hongo K; Tada T; Takizawa T; Kakizawa Y; Koyama J; Kobayashi S; Sakurai A; Hashizume K
No Shinkei Geka; 2000 Dec; 28(12):1087-92. PubMed ID: 11193530
[TBL] [Abstract][Full Text] [Related]
16. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
17. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
Nyquist P; Laws ER; Elliott E
Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
[TBL] [Abstract][Full Text] [Related]
18. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience.
Marić A; Kruljac I; Čerina V; Pećina HI; Šulentić P; Vrkljan M
Croat Med J; 2012 Jun; 53(3):224-33. PubMed ID: 22661135
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
20. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
